COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

F Götzinger; B Santiago-García; A Noguera-Julián; M Lanaspa; L Lancella; FI Calò Carducci; N Gabrovska; S Velizarova; P Prunk; V Osterman; U Krivec; A Lo Vecchio; D Shingadia; A Soriano-Arandes; S Melendo; M Lanari; L Pierantoni; N Wagner; AG L'Huillier; U Heininger; N Ritz; S Bandi; N Krajcar; S Roglić; M Santos; C Christiaens; M Creuven; D Buonsenso; SB Welch; M Bogyi; F Brinkmann; M Tebruegge; J Pfefferle; A Zacharasiewicz; A Berger; R Berger; V Strenger; DS Kohlfürst; A Zschocke; B Bernar; B Simma; E Haberlandt; C Thir; A Biebl; K Vanden Driessche; T Boiy; D Van Brusselen; A Bael; S Debulpaep; P Schelstraete; I Pavic; U Nygaard; JP Glenthoej; L Heilmann Jensen; I Lind; M Tistsenko; Ü Uustalu; L Buchtala; S Thee; R Kobbe; C Rau; N Schwerk; M Barker; M Tsolia; I Eleftheriou; P Gavin; O Kozdoba; B Zsigmond; P Valentini; I Ivaškeviciene; R Ivaškevicius; V Vilc; E Schölvinck; A Rojahn; A Smyrnaios; C Klingenberg; I Carvalho; A Ribeiro; A Starshinova; I Solovic; L Falcón; O Neth; L Minguell; M Bustillo; AM Gutiérrez-Sánchez; B Guarch Ibáñez; F Ripoll; B Soto; K Kötz; P Zimmermann; H Schmid; F Zucol; A Niederer; M Buettcher; BS Cetin; O Bilogortseva; V Chechenyeva; A Demirjian; F Shackley; L McFetridge

Journal article

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

F Götzinger, B Santiago-García, A Noguera-Julián, M Lanaspa, L Lancella, FI Calò Carducci, N Gabrovska, S Velizarova, P Prunk, V Osterman, U Krivec, A Lo Vecchio, D Shingadia, A Soriano-Arandes, S Melendo, M Lanari, L Pierantoni, N Wagner, AG L'Huillier, U Heininger Show all

Lancet Child and Adolescent Health | ELSEVIER SCI LTD | Published : 2020

DOI: 10.1016/S2352-4642(20)30177-2

Abstract

Background: To date, few data on paediatric COVID-19 have been published, and most reports originate from China. This study aimed to capture key data on children and adolescents with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection across Europe to inform physicians and health-care service planning during the ongoing pandemic. Methods: This multicentre cohort study involved 82 participating health-care institutions across 25 European countries, using a well established research network—the Paediatric Tuberculosis Network European Trials Group (ptbnet)—that mainly comprises paediatric infectious diseases specialists and paediatric pulmonologists. We included all individu..

View full abstract

University of Melbourne Researchers

Petra Zimmermann Author

Grants

Awarded by Gilead Sciences

Funding Acknowledgements

We express our gratitude to all colleagues and research personnel involved in the data collection for this study, as well as the members of the human research ethics committees and institutional review boards that have kindly fast-tracked this study. We are also grateful for the kind support of the Clinical Microbiology & Infectious Diseases Department and the COVID-19 Group at Hospital General Universitario Gregorio Maranon, Madrid, Spain. This project did not receive specific funding. ptbnet is supported by the Deutsche Gesellschaft fur Internationale Zusammenarbeit. BS-G is funded by the Spanish Ministry of HealthInstituto de Salud Carlos III and co-funded by the European Union (FEDER; Contrato Juan Rodes, Grant JR16/00036). AN-J was supported by "Subvencions per a la Intensificacio de Facultatius Especialistes"Departament de Salut de la Generalitat de Catalunya, Programa PERIS 2016-2020 (SLT008/18/00193).